22-21790964-T-C

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002745.5(MAPK1):​c.610-2156A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.54 in 152,054 control chromosomes in the GnomAD database, including 22,462 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.54 ( 22462 hom., cov: 32)

Consequence

MAPK1
NM_002745.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.05

Publications

8 publications found
Variant links:
Genes affected
MAPK1 (HGNC:6871): (mitogen-activated protein kinase 1) This gene encodes a member of the MAP kinase family. MAP kinases, also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. The activation of this kinase requires its phosphorylation by upstream kinases. Upon activation, this kinase translocates to the nucleus of the stimulated cells, where it phosphorylates nuclear targets. One study also suggests that this protein acts as a transcriptional repressor independent of its kinase activity. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Two alternatively spliced transcript variants encoding the same protein, but differing in the UTRs, have been reported for this gene. [provided by RefSeq, Jan 2014]
MAPK1 Gene-Disease associations (from GenCC):
  • Noonan syndrome 13
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.02).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.601 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002745.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPK1
NM_002745.5
MANE Select
c.610-2156A>G
intron
N/ANP_002736.3
MAPK1
NM_138957.3
c.610-2156A>G
intron
N/ANP_620407.1Q1HBJ4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAPK1
ENST00000215832.11
TSL:1 MANE Select
c.610-2156A>G
intron
N/AENSP00000215832.7P28482-1
MAPK1
ENST00000398822.7
TSL:1
c.610-2156A>G
intron
N/AENSP00000381803.3P28482-1
MAPK1
ENST00000544786.1
TSL:1
c.610-2156A>G
intron
N/AENSP00000440842.1P28482-2

Frequencies

GnomAD3 genomes
AF:
0.539
AC:
81944
AN:
151936
Hom.:
22425
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.603
Gnomad AMI
AF:
0.463
Gnomad AMR
AF:
0.612
Gnomad ASJ
AF:
0.613
Gnomad EAS
AF:
0.446
Gnomad SAS
AF:
0.473
Gnomad FIN
AF:
0.364
Gnomad MID
AF:
0.623
Gnomad NFE
AF:
0.519
Gnomad OTH
AF:
0.587
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.540
AC:
82038
AN:
152054
Hom.:
22462
Cov.:
32
AF XY:
0.534
AC XY:
39699
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.604
AC:
25026
AN:
41462
American (AMR)
AF:
0.612
AC:
9356
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.613
AC:
2128
AN:
3472
East Asian (EAS)
AF:
0.446
AC:
2291
AN:
5142
South Asian (SAS)
AF:
0.473
AC:
2284
AN:
4824
European-Finnish (FIN)
AF:
0.364
AC:
3852
AN:
10576
Middle Eastern (MID)
AF:
0.639
AC:
188
AN:
294
European-Non Finnish (NFE)
AF:
0.519
AC:
35260
AN:
67968
Other (OTH)
AF:
0.583
AC:
1232
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1917
3835
5752
7670
9587
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
704
1408
2112
2816
3520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.385
Hom.:
980
Bravo
AF:
0.559
Asia WGS
AF:
0.473
AC:
1646
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.3
DANN
Benign
0.32
PhyloP100
-2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11704205; hg19: chr22-22145253; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.